Your browser doesn't support javascript.
loading
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study.
Chen, Bowen; Zhang, Linzhi; Cheng, Jiamin; Wu, Tong; Lei, Jin; Yang, Xu; Zhang, Rongling; Safadi, Rifaat; Li, Yinyin; Si, Tongguo; Lu, Yinying.
Afiliação
  • Chen B; Peking University 302 Clinical Medical School, Beijing, People's Republic of China.
  • Zhang L; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Cheng J; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Wu T; Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Lei J; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Yang X; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Zhang R; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Safadi R; Guizhou Medical University, Guiyang, People's Republic of China.
  • Li Y; Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Si T; Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Lu Y; Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
Drug Des Devel Ther ; 16: 4429-4437, 2022.
Article em En | MEDLINE | ID: mdl-36597443

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Encefalopatia Hepática / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Drug Des Devel Ther Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Encefalopatia Hepática / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Drug Des Devel Ther Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article
...